Dapagliflozin

Post Date:
Nov 21,2014
Expiry Date:
Nov 21,2015
Detailed Description:
Cas No. :461432-26-8 HP4022 Dapagliflozin CAS 461432-26-8
Dapagliflozin CAS 461432-26-8 Brand: Hyper
MW:408.873 MSDS: Avaiable
MF :C21H25ClO6 Dapagliflozin
Category:Diabetes drug Min order: 10grams
Quality standard : Purity 99% min Place of Origin:China
Introduction Dapagliflozin is a drug used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca. Although dapagliflozin's method of action would operate on both types of diabetes and other conditions resulting in hyperglycemia, the current clinical trials specifically exclude participants with type 1 diabetes.
Applications Dapagliflozin A sodium-glucose transporter 2 inhibitor ,Pharmaceutical raw materials
CAS Registry Number:
461432-26-8
Synonyms:
;Dapagliflozin;BMS-512148;(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1s)-;Dapagliflozin free base;
Molecular Formula:
C₂₁H₂₅ClO₆
Molecular Weight:
408.8726
Molecular Structure:

Offter to Sell